Literature DB >> 19392871

Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease.

E S Lee1, N Kim, S H Lee, Y S Park, J W Kim, S H Jeong, D H Lee, H C Jung, I S Song.   

Abstract

BACKGROUND: There has been no report on the response to proton pump inhibitor (PPI) therapy and on-demand or the relapse rate of non-erosive reflux disease (NERD) and erosive oesophagitis in Korea. AIM: To compare the risk factors, clinical symptoms and PPI responses between patients with erosive oesophagitis and NERD patients.
METHODS: A survey was performed prospectively in the erosive oesophagitis (205 patients) and NERD group (200 patients). Clinical symptoms, risk factors and PPI responses were analysed. On-demand therapy and the relapse rate of GERD symptoms were investigated during a one-year follow-up.
RESULTS: BMI > or = 25 (OR 3.0, 95% CI 1.1-8.3), alcohol use (OR 2.9, 95% CI 1.0-8.3), hiatal hernia (OR 5.0, 95% CI 1.2-20) and triglyceride > or =150 mg/dL (OR 4.0, 95% CI 1.7-10) were more common in the erosive oesophagitis group than in the NERD group by multivariate analysis. The ratio of oesophageal to extra-oesophageal symptoms was higher in the erosive oesophagitis group compared with the NERD group (P < 0.001). The PPI response rates at 8 weeks were different (P = 0.02); refractory rates were higher in the NERD group (16.7%) compared with the erosive oesophagitis group (6.0%). However, there was no significant difference between the two groups in on-demand therapy or the relapse rate.
CONCLUSION: These results suggest that the underlying pathogenic mechanisms of erosive oesophagitis and NERD are distinct.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19392871     DOI: 10.1111/j.1365-2036.2009.04021.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  26 in total

1.  A study on the efficacy of rebamipide for patients with proton pump inhibitor-refractory non-erosive reflux disease.

Authors:  Kyoichi Adachi; Kenji Furuta; Hiroto Miwa; Tadayuki Oshima; Masaharu Miki; Yoshinori Komazawa; Katsuhiko Iwakiri; Takahisa Furuta; Tomoyuki Koike; Tomohiko Shimatani; Yoshikazu Kinoshita
Journal:  Dig Dis Sci       Date:  2012-02-26       Impact factor: 3.199

Review 2.  Is alcohol consumption associated with gastroesophageal reflux disease?

Authors:  Shao-hua Chen; Jie-wei Wang; You-ming Li
Journal:  J Zhejiang Univ Sci B       Date:  2010-06       Impact factor: 3.066

3.  Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life.

Authors:  Xiao-Jun Yang; Hong-Mei Jiang; Xiao-Hua Hou; Jun Song
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

4.  Nickel sensitization in patients with gastro-esophageal reflux disease.

Authors:  Vincenzo Stanghellini; Cesare Tosetti; Edoardo Benedetto; Mario Condoluci; Rudi De Bastiani; Rosanna Cogliandro; Tecla Mastronuzzi; Manuela De Polo; Francesco Di Mita; Luigi Napoli; Enzo Ubaldi; Cristina Nebiacolombo; Carmelo Cottone; Ignazio Grattagliano; Maria Zamparella; Elisabetta Baldi; Guido Sanna
Journal:  United European Gastroenterol J       Date:  2015-07-24       Impact factor: 4.623

5.  Non-erosive reflux disease rather than cervical inlet patch involves globus.

Authors:  Kazutoshi Hori; Yongmin Kim; Jun Sakurai; Jiro Watari; Toshihiko Tomita; Tadayuki Oshima; Chizuko Kondo; Takayuki Matsumoto; Hiroto Miwa
Journal:  J Gastroenterol       Date:  2010-06-26       Impact factor: 7.527

6.  Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology.

Authors:  Shobna J Bhatia; Govind K Makharia; Philip Abraham; Naresh Bhat; Ajay Kumar; D Nageshwar Reddy; Uday C Ghoshal; Vineet Ahuja; G Venkat Rao; Krishnadas Devadas; Amit K Dutta; Abhinav Jain; Saurabh Kedia; Rohit Dama; Rakesh Kalapala; Jose Filipe Alvares; Sunil Dadhich; Vinod Kumar Dixit; Mahesh Kumar Goenka; B D Goswami; Sanjeev K Issar; Venkatakrishnan Leelakrishnan; Mohandas K Mallath; Philip Mathew; Praveen Mathew; Subhashchandra Nandwani; Cannanore Ganesh Pai; Lorance Peter; A V Siva Prasad; Devinder Singh; Jaswinder Singh Sodhi; Randhir Sud; Jayanthi Venkataraman; Vandana Midha; Amol Bapaye; Usha Dutta; Ajay K Jain; Rakesh Kochhar; Amarender S Puri; Shivram Prasad Singh; Lalit Shimpi; Ajit Sood; Rajkumar T Wadhwa
Journal:  Indian J Gastroenterol       Date:  2019-12-05

7.  Comparison of Direct Medical Care Costs Between Erosive Reflux Disease and Non-erosive Reflux Disease in Korean Tertiary Medical Center.

Authors:  Pyoung Ju Seo; Nayoung Kim; Jane C Oh; Byoung Hwan Lee; Cheol Min Shin; Seungchul Suh; Hyunkyung Park; Ryoung Hee Nam; Jin A Cha; Young Soo Park; Dong Ho Lee
Journal:  J Neurogastroenterol Motil       Date:  2010-07-27       Impact factor: 4.924

8.  Risk factors for proton pump inhibitor refractoriness in Chinese patients with non-erosive reflux disease.

Authors:  Xiao-Ping Niu; Bao-Ping Yu; Yun-Dong Wang; Zhen Han; Shao-Fen Liu; Chi-Yi He; Guo-Zheng Zhang; Wan-Chun Wu
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

9.  Difference in efficacy of proton pump inhibitor between new-onset and recurrent gastroesophageal reflux disease: Result from a study of on-demand versus continuous maintenance therapy in Japan.

Authors:  A Nagahara; D Asaoka; M Hojo; H Sasaki; Y Shimada; K Matsumoto; H Ueyama; T Shibuya; N Sakamoto; T Osada; S Watanabe
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

10.  Effect of Helicobacter pylori Eradication on Functional Dyspepsia.

Authors:  Sung Eun Kim; Young Soo Park; Nayoung Kim; Min Soo Kim; Hyun Jin Jo; Cheol Min Shin; Sang Hyub Lee; Jin-Hyeok Hwang; Jin-Wook Kim; Sook-Hyang Jeong; Dong Ho Lee; Hyun Chae Jung
Journal:  J Neurogastroenterol Motil       Date:  2013-04-16       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.